Mohit  Kaushal net worth and biography

Mohit Kaushal Biography and Net Worth

Director of Oncology Institute

Dr. Mohit Kaushal has served as a director since March 10, 2020. He has had an extensive career within investing, clinical medicine and public policy. Dr. Kaushal has served as a special advisor to General Atlantic since 2015. He was a partner in Aberdare Ventures from 2013 to 2014. During his time in the Obama administration, he was a member of the White House Health IT task force; a cross agency team implementing the technology aspects of the ACA and testified to Congress on the application of technology and payment reform to the Medicare population. He also built and led the first dedicated healthcare team at the Federal Communications Commission, where his team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA. In addition, his team reformed the Rural Healthcare fund to create the Healthcare Connect Fund, which aligned the funding mechanism with wider healthcare payment policy and technology reform. Dr. Kaushal is a lead investor, board member or advisor to numerous transformational healthcare companies. Dr. Kaushal is an emergency room physician, holds an MBA from Stanford and an MD with distinction from Imperial College of Science, Technology and Medicine, London. He is an Adjunct Professor at Stanford University with a joint position within the newly created Biomedical Data Science Department and the medical school’s Clinical Excellence Research Center. Dr. Kaushal was selected to serve on the board of directors due to his significant management experience in the healthcare and technology industries.

What is Mohit Kaushal's net worth?

The estimated net worth of Mohit Kaushal is at least $666.17 thousand as of April 16th, 2026. Dr. Kaushal owns 172,583 shares of Oncology Institute stock worth more than $666,170 as of April 30th. This net worth estimate does not reflect any other investments that Dr. Kaushal may own. Learn More about Mohit Kaushal's net worth.

How do I contact Mohit Kaushal?

The corporate mailing address for Dr. Kaushal and other Oncology Institute executives is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. Oncology Institute can also be reached via phone at 562-735-3226 and via email at [email protected]. Learn More on Mohit Kaushal's contact information.

Has Mohit Kaushal been buying or selling shares of Oncology Institute?

In the last ninety days, Mohit Kaushal has sold $335,016.50 in shares of Oncology Institute stock. Most recently, Mohit Kaushal sold 38,433 shares of the business's stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $3.50, for a transaction totalling $134,515.50. Following the completion of the sale, the director now directly owns 172,583 shares of the company's stock, valued at $604,040.50. Learn More on Mohit Kaushal's trading history.

Who are Oncology Institute's active insiders?

Oncology Institute's insider roster includes Robert Carter (CFO), Jorey Chernett (Major Shareholder), Brad Hively (Director), Mohit Kaushal (Director), Mark Pacala (Director), Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.

Are insiders buying or selling shares of Oncology Institute?

In the last year, Oncology Institute insiders bought shares 6 times. They purchased a total of 568,985 shares worth more than $1,759,600.65. In the last year, insiders at the sold shares 12 times. They sold a total of 11,585,436 shares worth more than $34,668,174.42. The most recent insider tranaction occured on April, 16th when Director Mohit Kaushal sold 38,433 shares worth more than $134,515.50. Insiders at Oncology Institute own 8.5% of the company. Learn More about insider trades at Oncology Institute.

Information on this page was last updated on 4/16/2026.

Mohit Kaushal Insider Trading History at Oncology Institute

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2026Sell38,433$3.50$134,515.50172,583View SEC Filing Icon  
4/14/2026Sell57,286$3.50$200,501.00211,016View SEC Filing Icon  
11/14/2022Sell15,994$2.13$34,067.2225,534View SEC Filing Icon  
10/24/2022Sell4,798$4.96$23,798.0841,528View SEC Filing Icon  
See Full Table

Mohit Kaushal Buying and Selling Activity at Oncology Institute

This chart shows Mohit Kaushal's buying and selling at Oncology Institute by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncology Institute Company Overview

Oncology Institute logo
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Read More

Today's Range

Now: $3.86
Low: $3.66
High: $3.91

50 Day Range

MA: $3.10
Low: $2.55
High: $3.71

2 Week Range

Now: $3.86
Low: $2.02
High: $4.88

Volume

1,521,954 shs

Average Volume

1,898,432 shs

Market Capitalization

$381.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.17